NasdaqGS:CRNXPharmaceuticals
A Look At Crinetics Pharmaceuticals (CRNX) Valuation After Mixed Recent Share Performance
Recent share performance and context
Crinetics Pharmaceuticals (CRNX) has drawn investor attention after recent trading left the stock with a 0.5% decline over the past day and a 6.5% decline over the past week.
Those short term moves sit alongside a 14% gain over the past month and a 27% decline over the past 3 months. Together they present a mixed recent performance picture to weigh against the company’s clinical stage pipeline.
See our latest analysis for Crinetics Pharmaceuticals.
At the...